RecruitingNot ApplicableNCT07551609

Study of RRS® HA Long Lasting for Improving Facial Wrinkles and Skin Quality

Post-Market Interventional Clinical Investigation to Evaluate the Safety and Efficacy of RRS® HA Long Lasting for the Improvement of Facial Wrinkles and Skin Quality

Sponsor

Skin Tech Pharma Group S.L.U.

Enrollment

207 participants

Start Date

Apr 26, 2026

Study Type

INTERVENTIONAL

Conditions

Skin Quality Improvement Photoaging Photoaged Facial Skin Wrinkle Reduction

Summary

The objective of this clinical study is to confirm the clinical performance and long-term safety of the CE-marked RRS® HA Long Lasting in the treatment of skin photoaging and its consequences, with a primary focus on improving facial wrinkles and skin quality in healthy adults. The main questions it aims to answer are: the proportion of responders achieving a clinically significant change in facial wrinkles from baseline to Month 2 on both sides of the face; improvement in photodamage compared to the control group at 2 months. Researchers will compare the group treated with RRS® HA Long Lasting to an untreated control group to evaluate the product's effectiveness in improving facial wrinkles and skin quality.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called RRS® HA Long Lasting for people with photoaged facial skin, photoaging, and other related conditions. The study is currently recruiting participants at 5 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.